JDD analysis highlights racial gaps in JAK inhibitor dermatology trials Have you caught this new JDD, analysis on JAK inhibitor trials? Dermatologists and clinical investigators will likely find this review relevant…
Read More
Early clinical mapping of exosome therapies in dermatology points to promise and questions Have you seen this JDD article on exosome-based dermatologic therapies? A scoping review summarized human clinical work…
Read More
Eruptive Lentiginosis After Biologic Therapy Results and Literature Review in JDD Have you read this latest article from the JDD? A new case report plus systematic review addresses eruptive lentiginosis…
Read More
Updated long term and real world evidence on efficacy and safety This is a must-read JDD article on brodalumab in plaque psoriasis. The review summarizes long term clinical trial findings,…
Read More
A comparative evaluation finds promising concordance but highlights gaps that require In the February JDD, authors compared two large language models, ChatGPT and DeepSeek, against the 2021 American Academy of…
Read More
In this article from JDD: Excimer laser delivers measurable PASI gains but evidence is limited A JDD meta‑analysis of 308 nm excimer laser treatment for plaque psoriasis pooled four clinical…
Read More
Check Out Our Latest TSLS The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As part of its ongoing…
Read More
Psoriatic Arthritis Awareness Day: Reddit Sentiment Meets a Crohn’s Conundrum On September 28, Psoriatic Arthritis Awareness Day invites dermatologists to look beyond the clinic and into the digital communities where patients…
Read More
Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis Check our all-new video abstract from Christopher G. Bunick MD PhD, who gives structural insights into what makes some…
Read More
Curated by the JDD Editors Missed any of our August highlights? August is our psoriasis issue–a must-read. Catch up with this curated roundup from the JDD Editors—your guide to must-read articles…
Read More
Check Out JDD Corner’s Latest Author Spotlight Our latest Author Spotlight shines on Mark G. Lebwohl, MD, co-author of “Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination…
Read More
A Concise Look at the IMMPulse Trial Comparing Apremilast And Risankizumab In Moderate Plaque Psoriasis In a compelling video interview for the Journal of Drugs in Dermatology, Dr. Christopher Bunick…
Read More
